A small but intriguing new study found that some people with hepatitis C who underwent a liver transplant were eventually able to stop taking immunosuppressant drugs designed to keep the recipient from rejecting the new organ.. The surprising result, published Wednesday in the journal Science Translational Medicine, runs counter to what was previously believed—that having a disease such as hepatitis C that triggers an immune response inhibits the body's ability to tolerate a new organ. It also suggests a new avenue for future...
  